Ponad 7000 publikacji medycznych!
Statystyki za 2021 rok:
odsłony: 8 805 378
Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu tutaj
© Borgis - New Medicine 3/2014, s. 92-94
*Konrad Wroński1, 2
Inflammatory breast cancer – case report and review of literature
1Department of Oncology, Faculty of Medicine, University of Warmia and Mazury, Olsztyn, Poland
Head of Department: prof Sergiusz Nawrocki, MD, PhD
2Department of Surgical Oncology, Hospital Ministry of Internal Affairs with Warmia and Mazury Oncology Centre, Olsztyn, Poland
Head of Department: Andrzej Lachowski, MD
Summary
Inflammatory breast cancer is rare breast neoplasm. Because of its rarity, this cancer is often misdiagnosed as generalized dermatitis or mastitis. It is characterized by an aggressive behavior and rapid progression. Five year survival times have increased due to multimodal therapy but they are still much lower than for other breast cancers.
The author of this article presented a case of a 40-year-old Caucasian woman who was admitted to the hospital because of advanced inflammatory breast cancer. The progression of disease was very fast and the patient died before the start of chemotherapy treatment. The author performed a literature review on inflammatory breast cancer diagnosis and treatment.
INTRODUCTION
Inflammatory breast cancer is rare breast neoplasm (1-3). Because of its rarity, this cancer is often misdiagnosed as generalized dermatitis or mastitis (4). It is characterized by an aggressive behavior and rapid progression (2, 4, 5). Five year survival times have increased due to multimodal therapy but they are still much lower than for other breast cancers (1-4).
CASE REPORT
A 40-year-old Caucasian woman was referred to the Department of Surgical Oncology due to swelling and redness of the right breast of two months (fig. 1, 2). For a month she reported increasing swelling of the right half of the face and redness with palpable nodules on the right side of the neck (fig. 3, 4). She reported general weakness and malaise. In the interview, the patient reported no fever. According to the patient the rate of change was very fast.
Fig. 1. Edema and redness of the right breast for 2 months in a 40-year-old Caucasian woman.
Fig. 2. Edema and redness of the right breast.
Fig. 3. The patient reported for a month increasing swelling of the right half of the face and redness with palpable nodules on the right side of the neck.
Fig. 4. Redness and enlarge palpable lymph nodes on the right side of the neck.
She had no any other symptoms, there was no history of weight loss and loss of appetite. The patient was not treated for chronically diseases. She had no surgeries and there was no history of carcinoma in patient family. Blood test and other routine hematological examinations and biochemical tests were within normal limits.

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
  • Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
  • Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
  • Aby kupić kod proszę skorzystać z jednej z poniższych opcji.

Opcja #1

19

Wybieram
  • dostęp do tego artykułu
  • dostęp na 7 dni

uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony

Opcja #2

49

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 30 dni
  • najpopularniejsza opcja

Opcja #3

119

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 90 dni
  • oszczędzasz 28 zł
Piśmiennictwo
1. Hance KW, Anderson WF, Devesa SS et al.: Trends in inflammatory breast carcinoma incidence and survival: the surviveillance, epidemiology and results program at the National Cancer Institute. J Natl Cancer Inst 2005; 97; 966-975. 2. Dawood S, Cristofanilli M: Inflamatory breast cancer: what progress have we made? Oncology 2011; 25(3): 264-270. 3. Yang WT, Le-Petross HT, Macapinlac H et al.: Inflammatory breast cancer: PET/CT, MRI, mammography and sonography findings. Breast Cancer Res Treat 2008; 109(3): 417-426. 4. Dawood S, Cristofanilli M: What progress have we made in imaging inflammatory breast cancer? Oncology 2007; 21: 673-679. 5. Walshe JM, Swain SM: Clinical aspects of inflammatory breast cancer. Breast Dis 2005; 22: 35-44. 6. Chow CK: Imaging in inflammatory breast carcinoma. Breast Dis 2005; 22: 45-54. 7. Lee KW, Chung SY, Yang I et al.: Inflammatory breast cancer: imaging findings. Clin Imaging 2005; 29: 22-25. 8. Eubank WB, Mankoff DA: Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 2005; 35: 84-99. 9. Yang WT, Le-Petross HT, Macapinlac H et al.: Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2008; 109: 417-426. 10. Curcio LD, Rupp E, Williams WL et al.: Beyond palliative mastectomy in inflammatory breast cancer – a reassessment of margin status. Ann Surg Oncol 1999; 6:249-254. 11. Bristol IJ, Woodward WA, Strom EA et al.: Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 2008; 72: 474-484. 12. Thomas WW Jr, McNeese MD, Fletcher GH et al.: Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 1989; 17: 739-745. 13. Arthur DW, Schmidt-Ullrich RK, Friedman RB et al.: Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation. Int J Radiat Oncol Biol Phys 1999; 44: 289-296.
otrzymano: 2014-07-14
zaakceptowano do druku: 2014-08-19

Adres do korespondencji:
*Konrad Wroński
General Surgery Consultant Department of Surgical Oncology Faculty of Medicine University of Warmia and Mazury, Olsztyn
37 al. Wojska Polskiego, 10-228 Olsztyn, Poland
e-mail: konradwronski@wp.pl

New Medicine 3/2014
Strona internetowa czasopisma New Medicine